FEops HEARTguide Authorized by FDA for Unprecedented LAAo Planning Capabilities
FEops today announced that it received De Novo authorization from the U.S. Food and Drug Administration (FDA) for FEops HEARTguide pre-operative planning of left atrial appendage occlusion with the
United States United Kingdom British Columbia Kostenloser Wertpapierhandel Peter Mortier Feops Heartguide
Source: finanznachrichten.de